Skip to content

ProspEctive First Evaluation in Chest Pain Trial

ProspEctive Randomized First Evaluation in Chest Pain Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01604655
Acronym
PERFECT
Enrollment
411
Registered
2012-05-24
Start date
2011-09-30
Completion date
2015-12-31
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain, Shortness of Breath, Suspected Acute Coronary Syndrome

Keywords

Chest pain, shortness of breath, suspected acute coronary syndrome, stress testing, coronary computed tomography angiography

Brief summary

The purpose of this study is to determine the best initial test in patients admitted to the hospital complaining of chest pain.

Detailed description

Currently, physicians can either choose a stress test or a CT scan of the heart to evaluate patients admitted with with chest pain. Very little is known about which test provides the best information to physicians, positively impacts patients medical care, and decreases future hospital admissions and testing. To study this the investigators are randomizing patients admitted to our hospital with chest pain to a stress test or coronary CT angiography. The investigators will then follow these patients for a 2 year period.

Interventions

PROCEDUREStress Test

Stress Test

Sponsors

St. Luke's-Roosevelt Hospital Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with chest pain or SOB admitted for rule out acute coronary syndrome * Age ≥45 years * EKG non-diagnostic for acute coronary syndrome * At least 1 set of negative troponin I

Exclusion criteria

* Patient with ST elevation myocardial infarction. * Patients with non-ST elevation myocardial infarction. * Patients with known CAD. * Patients with serum creatinine \> 1.5. * Atrial fibrillation or marked irregular heart rhythm. * Patients in whom heart rate cannot be controlled. * Patient with allergies to iodinated contrast agents. * Pregnant women * Patients unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Time to dischargeInitial hospitalization
Change in medical regimenInitial hospitalization
Downstream cardiovascular testing and hospitalization2 years

Secondary

MeasureTime frameDescription
All-cause mortality7 days, 30 days, 6, 12, and 24 months.This measure is to ascertain if CCTA and stress testing can be used safely as the initial test in patients admitted to the hospital with chest pain.
Cardiovascular mortality7 days, 30 days, 6, 12, and 24 months.This measure is to ascertain if CCTA and stress testing can be used safely as the initial test in patients admitted to the hospital with chest pain.
Non-fatal myocardial infarction7 days, 30 days, 6, 12, and 24 months.This measure is to ascertain if CCTA and stress testing can be used safely as the initial test in patients admitted to the hospital with chest pain.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026